SPARC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sun Pharma Advanced Research Co Ltd

Watchlist Manager

Watchlist

Price: 205.8 INR -1.67% Market Closed

Market Cap: ₹66.8B

S	Sun Pharma Advanced Research Co Ltd BSE:532872	IN
	AML3D Ltd F:4YP	AU
P	PennantPark Floating Rate Capital Ltd NYSE:PFLT	US
	Jungfraubahn Holding AG SIX:JFN	CH
	Sensus Healthcare Inc F:5TX	US

Profitability Summary

Sun Pharma Advanced Research Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

17%

Sustainable 3Y Average Gross Margin

35%

Declining Gross Margin

23% > 17%

Negative Operating Margin

-449%

Negative 3Y Average Operating Margin

-443%

Declining Operating Margin

-94% > -449%

Negative Net Margin

-504%

Negative 3Y Average Net Margin

-440%

Declining Net Margin

-93% > -504%

Negative Free Cash Flow Margin

-572%

Negative 3Y Average Free Cash Flow Margin

-477%

Declining Free Cash Flow Margin

-35% > -572%

Exceptional ROE

127%

Positive 3Y Average ROE

Negative 3Y Average ROIC

-209%

Declining ROIC

-96% > -119%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.